Protective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation

RENOPROTECTIVE EFFECT OF LEFLUNOM1DE AGANIST ISCHEMIA-REPERFUSION INJURY IN RATS

Histological Study of the Effects of Empagliflozin Therapy on the Myocardium of Hypertensive Wister Adult Male Albino Rats

POTENTIAL EFFECT OF CAPTOPRIL, VALSARTAN ON NUCLEAR FACTOR KAPPA B AND LIPID PEROXIDATION IN HEPATIC ISCHEMIAREPERFUSION INJURY IN RATS.

Possible Protective Mechanisms of Sitagliptin against Isoproternol Induced Myocardial Injury in Rat

METFORMIN AND CARVEDILOL AMELIORATE ISOPRENALINE-INDUCED MYOCARDIAL INFARCTION IN NON-DIABETIC RATS THROUGH AMPK ACTIVATION AND SUPPRESSION OF APOPTOSIS

The Beneficial Effects of Sitagliptin, a Dipeptedyl Peptidase-4 (DPP-4) Inhibitor on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

Potential Hepatic Protection by Erythropoietin and Ischemic Conditioning in a Rat Model of Renal Ischemia-Reperfusion Injury

Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction Induced Experimentally in Diabetic Rats

The Potential Ameliorative Effect of Empagliflozin on Myocardium in Cardiorenal Syndrome 3 via Targeting Mitophagy and Mitochondrial Biogenesis in Adult Male Albino Rat Model: Bi